Marker Therapeutics Inc (MRKR)

[ah86]

i understand both points (yours and Buck). However i work for a non-profit and it is absolutely a sign of maturity, financial acumen, and presence of morals to manage funds. This 1-12 r/s you speak of and the decline over the years here with nothing but a building and promises of more trials to show, is anything but good management.
I do not see how this price can recover even with stellar interim data.
They have muck this one up. And anything short of a miraculous rise above $1 without a rs should result in letter of resignation from the CEO.